文献速递生殖医学

无宫腔受累的壁间子宫肌瘤对单次新鲜囊胚移植周期体外受精结局的影响

The Effect of Intramural Myomas Without an Intracavity Component on In Vitro Fertilization Outcomes in Single Fresh Blastocyst Transfer Cycles.
PubMed 文献 · J Minim Invasive Gynecol · 2018-03-09

回顾性队列研究纳入929个新鲜单囊胚移植周期,其中94例仅有非宫腔扭曲性壁间肌瘤、764例无肌瘤。肌瘤组促性腺激素用量更高(平均2653±404 IU vs 2350±1368 IU,p=.04),临床妊娠率(47% vs 32%,p=.005)和活产率(37.8% vs 25.5%,p=.02)均低于无肌瘤组。即使仅有1个肌瘤,临床妊娠率(OR 0.53,95%CI 0.33-0.83)和活产率(OR 0.56,95%CI 0.35-0.92)也显著降低。

要点

  • 非宫腔扭曲性壁间肌瘤患者促性腺激素用量更高(2653±404 IU vs 2350±1368 IU,p=.04)。
  • 肌瘤组临床妊娠率47% vs 无肌瘤组32%(p=.005),活产率37.8% vs 25.5%(p=.02)。
  • 即使仅1个肌瘤,临床妊娠率(OR 0.53,95%CI 0.33-0.83)和活产率(OR 0.56,95%CI 0.35-0.92)也显著降低。

核心结论

  • 相对较小(>1.5 cm)的非宫腔扭曲性壁间肌瘤对体外受精周期的临床妊娠率和活产率有负面影响,即使仅有1个肌瘤。

研究设计与样本

  • 回顾性队列研究(加拿大任务force分类II-2),学术生育中心,共纳入929个新鲜单囊胚移植周期,其中94例仅有非宫腔扭曲性壁间肌瘤,764例无肌瘤;排除卵裂期胚胎移植以减少胚胎质量偏倚。

主要发现

  • 肌瘤组与无肌瘤组在孕次、产次和体重指数方面无差异。
  • 肌瘤组促性腺激素用量高于无肌瘤组(平均2653±404 IU vs 2350±1368 IU,p=.04)。
  • 肌瘤组与无肌瘤组获取的成熟卵母细胞总数和形成的囊胚总数相似。
  • 肌瘤组临床妊娠率低于无肌瘤组(47% vs 32%,p=.005),活产率也低于无肌瘤组(37.8% vs 25.5%,p=.02)。
  • 即使仅有1个肌瘤,临床妊娠率(OR 0.53,95%CI 0.33-0.83)和活产率(OR 0.56,95%CI 0.35-0.92)也显著降低;在肌瘤>1.5 cm的患者中,校正年龄、吸烟、移植胚胎质量、窦卵泡计数和促性腺激素剂量后,活产率仍显著降低(OR 0.53,95%CI 0.29-0.97),而纳入所有肌瘤(包括直径<1.5 cm)时该活产率结果不显著,但临床妊娠率仍显著降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To assess clinical pregnancy rate (CPR) and live birth rate (LBR) in the presence of non-cavity-deforming intramural myomas in single fresh blastocyst transfer cycles. DESIGN: Retrospective cohort study (Canadian Task Force classification II-2). SETTING: Academic fertility center. PATIENTS: A total of 929 fresh single blastocyst transfer cycles were included, 94 with only non-cavity-distorting intramural myomas and 764 without myomas. Cleavage embryo transfers were excluded to reduce bias based on embryo quality. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: CPR and LBR were assessed. There were no differences noted in gravidity, parity, or body mass index between patients with myomas and those without myomas. Women with myomas required higher doses of gonadotropins (mean, 2653 ± 404 IU vs 2350 ± 1368 IU; p = .04) than women without myomas. However, the total number of mature oocytes collected and the total number of blastocysts created were similar. CPR (47% vs 32%; p = .005) and LBR (37.8% vs 25.5%; p = .02) were lower in patients who had intramural myomas compared with those without myomas. CPR and LBR were significantly reduced in the presence of even 1 myoma (odds ratio [OR], 0.53; 95% confidence interval [CI], 0.33-0.83 and OR, 0.56; 95% CI, 0.35-0.92, respectively). In patients with myomas >1.5 cm, LBR was also significantly reduced, even after adjusting for age, smoking, quality of embryo transferred, antral follicle count, and dose of gonadotropins (OR, 0.53; 95% CI, 0.29-0.97). This LBR finding was not significant if all myomas were included (including those <1.5 cm in diameter), but CPR was still significantly reduced. CONCLUSION: Relatively small (>1.5 cm) non-cavity-distorting intramural myomas negatively affect CPR and LBR in in vitro fertilization cycles, even in the presence of only 1 myoma.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Behbehani S, Polesello S, Hasson J, et al. The Effect of Intramural Myomas Without an Intracavity Component on In Vitro Fertilization Outcomes in Single Fresh Blastocyst Transfer Cycles. J Minim Invasive Gynecol. 2018. PMID: 29530836. doi:10.1016/j.jmig.2018.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。